Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2018 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Modifiable factors influencing relapses and disability in multiple sclerosis.
D'hooghe MB, Nagels G, Bissay V, De Keyser J. D'hooghe MB, et al. Mult Scler. 2010 Jul;16(7):773-85. doi: 10.1177/1352458510367721. Epub 2010 May 18. Mult Scler. 2010. PMID: 20483884 Review.
Strong evidence suggests that relapses can be triggered by infections, the postpartum period and stressful life events. Vaccinations against influenza, hepatitis B and tetanus appear to be safe. Surgery, general and epidural anaesthesia, and physical trauma are not associa …
Strong evidence suggests that relapses can be triggered by infections, the postpartum period and stressful life events. Vaccinations against …
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.
Devogelaere J, D'hooghe MB, Vanderhauwaert F, D'haeseleer M. Devogelaere J, et al. Neurol Sci. 2020 Aug;41(8):1981-1983. doi: 10.1007/s10072-020-04522-2. Epub 2020 Jun 20. Neurol Sci. 2020. PMID: 32564270 Free PMC article.
We would like to present the first case report of a patient who was formally diagnosed with COVID-19 while being under disease-modifying treatment with rituximab, an anti-CD20 B cell depleting agent, for multiple sclerosis. The clinical picture was mild for which we have t …
We would like to present the first case report of a patient who was formally diagnosed with COVID-19 while being under disease-modifying tre …